13F HOLDINGS REPORT
Propel Bio Management, LLC
Quarter ended Q2 2025 · Filed August 13, 2025 · Accession 0000898432-25-000591
Total Value
$82.4M
Positions
16
Other Managers
1
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PLAINS GP HOLDINGS LP-CL | PAGP | 1,272,360 | $24.7M | 30.01% |
| 2 | ACHIEVE LIFE SCIENCES INC | ACHV | 6,153,091 | $13.9M | 16.88% |
| 3 | AKERO THERAPEUTICS INC | 00973Y108 | 228,884 | $12.2M | 14.82% |
| 4 | PHATHOM PHARMACEUTICALS I | PHAT | 922,927 | $8.9M | 10.74% |
| 5 | ABEONA THERAPEUTICS INC | ABEO | 974,022 | $5.5M | 6.71% |
| 6 | APPLIED THERAPEUTICS INC | 03828A101 | 11,285,420 | $3.5M | 4.26% |
| 7 | MILESTONE PHARMACEUTICALS | MIST | 1,791,557 | $3.5M | 4.22% |
| 8 | DELCATH SYSTEMS INC | DCTH | 226,052 | $3.1M | 3.73% |
| 9 | TSCAN THERAPEUTICS INC | TCRX | 2,087,139 | $3.0M | 3.67% |
| 10 | ZEVRA THERAPEUTICS INC | ZVRA | 231,874 | $2.0M | 2.48% |
| 11 | CAPRICOR THERAPEUTICS INC | CAPR | 70,000 | $695,100 | 0.84% |
| 12 | MAAT PHARMA SACA | F5888J116 | 94,181 | $452,069 | 0.55% |
| 13 | ATHIRA PHARMA INC | 04746L104 | 1,492,792 | $450,823 | 0.55% |
| 14 | EIGER BIOPHARMACEUTICALS | 28249U204 | 146,381 | $423,000 | 0.51% |
| 15 | WTS - Achieve Life Sci | 004468187 | 3,699,999 | $13,687 | 0.02% |
| 16 | CHINOOK THERAPEUTICS | 169CVR016 | 79,357 | $2,500 | 0.00% |